Atogepant (Qulipta (R)) for migraine prevention

Journal article

Peer reviewed

Debbie L. Hay, Christopher S. Walker and Paul W. R. Harris

Trends in pharmacological sciences (Regular ed.), Vol.43(8), pp.701-702

01/08/2022

Handle:

https://hdl.handle.net/10523/20275

Abstract

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Science & Technology

8 Record Views

Record Identifier: 9926495407701891
Title: Atogepant (Qulipta (R)) for migraine prevention
Creators: Debbie L. Hay
Christopher S. Walker
Paul W. R. Harris
Publication Details: Trends in pharmacological sciences (Regular ed.), Vol.43(8), pp.701-702
Academic Unit: Pharmacology and Toxicology
Publisher: Elsevier
Grant note: Abbvie; AbbVie Living Cell Technologies
Date published ; e-published: 01/08/2022
Language: English
Resource Type ; Subtype: Journal article